Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.…
Spectral AI, Inc. Q3 2026 Earnings Call Summary
Spectral AI (NASDAQ: MDAI) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 65 employees.
The shares were at 1.040 USD on 20 November 2026, down 46.4% over 52 weeks. Its 52-week range is 1.000 USD to 2.970 USD: the price is 65.0% below the high and 4.0% above the low.
Its market capitalisation is 33.47M USD.
Spectral AI reports return on equity of 132.2%, an operating margin of -86.5% and revenue down 24.7% year over year.
Its debt exceeds its cash by 5.39M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 23 March 2027.